Literature DB >> 24014879

Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Katerina Oikonomopoulou1, Robert A DeAngelis, Hui Chen, Eleftherios P Diamandis, Morley D Hollenberg, Daniel Ricklin, John D Lambris.   

Abstract

Activation of the complement system is primarily initiated by pathogen- and damage-associated molecular patterns on cellular surfaces. However, there is increasing evidence for direct activation of individual complement components by extrinsic proteinases as part of an intricate crosstalk between physiological effector systems. We hypothesized that kallikrein-related peptidases (KLKs), previously known to regulate inflammation via proteinase-activated receptors, can also play a substantial role in innate immune responses via complement. Indeed, KLKs exemplified by KLK14 were efficiently able to cleave C3, the point of convergence of the complement cascade, indicating a potential modulation of C3-mediated functions. By using in vitro fragmentation assays, mass spectrometric analysis, and cell signaling measurements, we pinpointed the generation of the C3a fragment of C3 as a product with potential biological activity released by the proteolytic action of KLK14. Using mice with various complement deficiencies, we demonstrated that the intraplantar administration of KLK14 results in C3-associated paw edema. The edema response was dependent on the presence of the receptor for C3a but was not associated with the receptor for the downstream complement effector C5a. Our findings point to C3 as one of the potential substrates of KLKs during inflammation. Given the wide distribution of the KLKs in tissues and biological fluids where complement components may also be expressed, we suggest that via C3 processing, tissue-localized KLKs can play an extrinsic complement-related role during activation of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24014879      PMCID: PMC3922206          DOI: 10.4049/jimmunol.1202999

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  A rapid FPLC method for purification of the third component of human and guinea pig complement.

Authors:  M Basta; C H Hammer
Journal:  J Immunol Methods       Date:  1991-08-28       Impact factor: 2.303

3.  Characterization of tryptic fragments of human complement factor C3.

Authors:  G Eggertsen; U Hellman; A Lundwall; J Folkersen; J Sjöquist
Journal:  Mol Immunol       Date:  1985-08       Impact factor: 4.407

4.  Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.

Authors:  F W Orr; J Varani; D L Kreutzer; R M Senior; P A Ward
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

5.  Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.

Authors:  R A Wetsel; W P Kolb
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.

Authors:  Y Fukuoka; T E Hugli
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

7.  Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis.

Authors:  J A Wingrove; R G DiScipio; Z Chen; J Potempa; J Travis; T E Hugli
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

8.  The activation of the alternative pathway C3 convertase by human plasma kallikrein.

Authors:  R G DiScipio
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

9.  A mechanism of action for anaphylatoxin C3a stimulation of mast cells.

Authors:  M Mousli; T E Hugli; Y Landry; C Bronner
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

10.  Third component of complement (C3): structural properties in relation to functions.

Authors:  V A Bokisch; M P Dierich; H J Mūller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

View more
  8 in total

1.  Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.

Authors:  Michael Panos; George P Christophi; Moses Rodriguez; Isobel A Scarisbrick
Journal:  Biol Chem       Date:  2014-09       Impact factor: 3.915

Review 2.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 3.  Proteinases and their receptors in inflammatory arthritis: an overview.

Authors:  Katerina Oikonomopoulou; Eleftherios P Diamandis; Morley D Hollenberg; Vinod Chandran
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

Review 4.  Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Authors:  Srilakshmi Srinivasan; Thomas Kryza; Jyotsna Batra; Judith Clements
Journal:  Nat Rev Cancer       Date:  2022-01-31       Impact factor: 69.800

Review 5.  Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Authors:  Markus Huber-Lang; Kristina N Ekdahl; Rebecca Wiegner; Karin Fromell; Bo Nilsson
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

6.  Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.

Authors:  Jee Suk Chang; Nalee Kim; Ji Ye Kim; Sung Im Do; Yeona Cho; Hyun Soo Kim; Yong Bae Kim
Journal:  J Gynecol Oncol       Date:  2020-11       Impact factor: 4.401

Review 7.  Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.

Authors:  Zivile Bekassy; Ingrid Lopatko Fagerström; Michael Bader; Diana Karpman
Journal:  Nat Rev Immunol       Date:  2021-11-10       Impact factor: 108.555

Review 8.  The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets.

Authors:  Morley D Hollenberg; Murray Epstein
Journal:  Kidney Int Suppl (2011)       Date:  2022-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.